PHARMAGREEN BIOTECH INC. Diluted Shares Outstanding (Weighted Average)
PHARMAGREEN BIOTECH INC. reported Diluted Shares Outstanding (Weighted Average) of 218.66 million shares for the 12-month period ending 2022-09-30, per its 10-K filed 2023-01-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2023-01-17
- PHARMAGREEN BIOTECH INC. weighted average number of shares outstanding, diluted for the quarter ending 2022-09-30 was -310.49M shares, a 163.38% decline year-over-year.
- PHARMAGREEN BIOTECH INC. weighted average number of shares outstanding, diluted for the quarter ending 2022-06-30 was 613.47M shares, a 74.40% increase year-over-year.
- PHARMAGREEN BIOTECH INC. weighted average number of shares outstanding, diluted for the quarter ending 2021-09-30 was 489.92M shares, a 24.29% increase year-over-year.
- PHARMAGREEN BIOTECH INC. weighted average number of shares outstanding, diluted for the quarter ending 2021-06-30 was 351.76M shares, a 14.49% decline year-over-year.
- PHARMAGREEN BIOTECH INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 218.66M shares, a 32.94% decline from fiscal 2021.
- PHARMAGREEN BIOTECH INC. weighted average number of shares outstanding, diluted for fiscal 2021 was 326.05M shares, a 16.05% decline from fiscal 2020.
- PHARMAGREEN BIOTECH INC. weighted average number of shares outstanding, diluted for fiscal 2020 was 388.37M shares, a 6.45% increase from fiscal 2019.
- PHARMAGREEN BIOTECH INC. weighted average number of shares outstanding, diluted for fiscal 2019 was 364.85M shares, a 24.48% increase from fiscal 2018.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2022-09-30 | -310.49M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | 151.49M shares derived: average of 2 quarters · filed 2023-01-17 | 218.66M shares 10-K · filed 2023-01-17 | |
| 2022-06-30 | 613.47M shares 10-Q · filed 2022-08-17 | 395.04M shares 10-Q · filed 2022-08-17 | ||
| 2021-09-30 | 489.92M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | 420.84M shares derived: average of 2 quarters · filed 2023-01-17 | 326.05M shares 10-K · filed 2023-01-17 | |
| 2021-06-30 | 351.76M shares 10-Q · filed 2022-08-17 | 271.42M shares 10-Q · filed 2022-08-17 | ||
| 2020-09-30 | 394.17M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-29 | 402.78M shares derived: average of 2 quarters · filed 2021-12-29 | 388.37M shares 10-K · filed 2021-12-29 | |
| 2020-06-30 | 411.38M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-19 | 386.44M shares 10-Q · filed 2020-08-19 | ||
| 2020-03-31 | 373.97M shares 10-Q · filed 2020-05-19 | |||
| 2019-09-30 | 364.85M shares 10-K · filed 2021-01-08 | |||
| 2018-09-30 | 293.10M shares 10-K · filed 2019-12-30 |